FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

FDA Reiterates NuVasive Device Indications

FDA reiterates the indication and instructions for use of the NuVasive Specialized Orthopedics Precice Intramedullary Limb Lengthening system.

latest-news-card-1
Medical Devices

Candela Laser Cleared for Capillary Malformations

FDA clears a Candela 510(k) to expand the labeled indication of its Vbeam Pulsed Dye Laser for use of the 595 nm wavelength to include treating pediat...

latest-news-card-1
Medical Devices

Overject AI Technology for Dental Caries Cleared

FDA clears an Overjet 510(k) to expand the use of its artificial intelligence technology for predicting tooth decay in younger patients.

latest-news-card-1
Human Drugs

Pfizer/OPKO Pediatric Growth Hormone OKd

FDA approves a Pfizer and OPKO Health BLA for Ngenla (somatrogon-ghla), a once-weekly, human growth hormone analog indicated for treating pediatric pa...

latest-news-card-1
Human Drugs

Eton Pharma Gets Complete Response Letter

FDA sends Eton Pharmaceuticals a second complete response letter on its NDA for dehydrated alcohol injection for treating methanol poisoning.

latest-news-card-1
Federal Register

Compounded Drug Wholesaling Prohibition Guide

Federal Register notice: FDA makes available a draft guidance entitled Prohibition on Wholesaling Under Section 503B of the Federal Food, Drug, and Co...

latest-news-card-1
Human Drugs

4 Observations in Prisma Health FDA-483

FDA releases the form FDA-483 with four observations issued following an inspection at the Prisma Health outsourcing facility in Simpsonville, SC.

latest-news-card-1
Federal Register

Guide on Quantitative Data in DTC Materials

Federal Register notice: FDA makes available a final guidance entitled Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer (DT...

latest-news-card-1
Human Drugs

FDA Bars Chengdu KeCheng Drugs

FDA issues an Import Alert against all drugs from Chinas Chengdu KeCheng Fine Chemicals and a Warning Letter about its continuing failure to respond t...

latest-news-card-1
Human Drugs

New Lilly Drug Meets Endpoints on Weight Loss

Eli Lilly says new Phase 2 data on weight-loss candidate retatrutide met primary and secondary endpoints.